Considering the important advances in treating specific types of systemic amyloidoses, unequivocal typing of amyloid deposits is now essential. Subcutaneous abdominal fat aspiration is the easiest, most common diagnostic procedure. We developed a novel, automated approach, based on Multidimensional Protein Identification Technology, for typing amyloidosis. Fat aspirates were obtained from patients with the most common systemic amyloidoses (ALλ, ALκ, transthyretin, and reactive amyloidosis), with Congo red score more than or equal to 3+, and nonaffected controls. Peptides from extracted and digested proteins were analyzed by Multidimensional Protein Identification Technology. On semiquantitative differential analysis (patients vs controls) of mass spectrometry data, specific proteins up-represented in patients were identified and used as deposit biomarkers. An algorithm was developed to classify patients according to type and abundance of amyloidogenic proteins in samples; in all cases, proteomic characterization was concordant with fibril identification by immunoelectron microscopy and consistent with clinical presentation. Our approach allows reliable amyloid classification using readily available fat aspirates.

Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue

LAVATELLI, FRANCESCA;PALLADINI, GIOVANNI;MERLINI, GIAMPAOLO
2012-01-01

Abstract

Considering the important advances in treating specific types of systemic amyloidoses, unequivocal typing of amyloid deposits is now essential. Subcutaneous abdominal fat aspiration is the easiest, most common diagnostic procedure. We developed a novel, automated approach, based on Multidimensional Protein Identification Technology, for typing amyloidosis. Fat aspirates were obtained from patients with the most common systemic amyloidoses (ALλ, ALκ, transthyretin, and reactive amyloidosis), with Congo red score more than or equal to 3+, and nonaffected controls. Peptides from extracted and digested proteins were analyzed by Multidimensional Protein Identification Technology. On semiquantitative differential analysis (patients vs controls) of mass spectrometry data, specific proteins up-represented in patients were identified and used as deposit biomarkers. An algorithm was developed to classify patients according to type and abundance of amyloidogenic proteins in samples; in all cases, proteomic characterization was concordant with fibril identification by immunoelectron microscopy and consistent with clinical presentation. Our approach allows reliable amyloid classification using readily available fat aspirates.
2012
The Research/Laboratory Medicine & Medical Technology category includes resources on pathology, forensic sciences, medical genetics, biotechnology, and biomedical engineering. Coverage also includes clinical monitoring and computing devices; medical instrumentation; and artificial organs, medical implants, and other emerging medical treatments.
Esperti anonimi
Inglese
Internazionale
STAMPA
119
8
1844
1847
4
Amyloidosis; typing; proteomics
http://bloodjournal.hematologylibrary.org/content/119/8/1844.full.pdf+html
no
10
info:eu-repo/semantics/article
262
Brambilla, F.; Lavatelli, Francesca; Di Silvestre, D.; Valentini, V.; Rossi, R.; Palladini, Giovanni; Obici, L.; Verga, L.; Mauri, P.; Merlini, Giampa...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/578113
Citazioni
  • ???jsp.display-item.citation.pmc??? 41
  • Scopus 178
  • ???jsp.display-item.citation.isi??? 156
social impact